Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 1 (2005), Issue 1 (October)

1. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
   Int J Radiat Oncol Biol Phys, 63(3): 788-94. [Abstract] [Full-text]
2. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
   Int J Radiat Oncol Biol Phys, 63(3): 667-71. [Abstract] [Full-text]
3. Mum knows best? Psychological status in an oncology sample.
   Child Care Health Dev, 31(6): 643-8. [Abstract] [Full-text]
4. Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology.
   Autoimmun Rev, 4(8): 503-9. [Abstract] [Full-text]
5. PET/CT in oncology--a major advance.
   Clin Radiol, 60(11): 1143-55. [Abstract] [Full-text]
6. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey.
   Head Neck, 27(11): 952-8. [Abstract] [Full-text]
7. Obesity in pediatric oncology.
   Pediatr Blood Cancer, 45(7): 881-91. [Abstract] [Full-text]
8. Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
   Ann Oncol, 16(11): 1762-71. [Abstract] [Full-text]
9. Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
   Gynecol Oncol, 99(2): 339-42. [Abstract] [Full-text]
10. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.
    Mutat Res, 587(1): 45-51. [Abstract] [Full-text]
11. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Cytometry B Clin Cytom, 68(1): 18-24. [Abstract] [Full-text]
12. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
    Br J Cancer, 93(9): 993-8. [Abstract] [Full-text]
13. Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.
    Cancer Chemother Pharmacol, 56(5): 481-6. [Abstract] [Full-text]
14. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.
    Lancet Oncol, 6(11): 841-50. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.